(Total Views: 369)
Posted On: 05/18/2021 8:32:42 AM
Post# of 36564
This CYDY discussion reminds me of GNBT being in discussions with research institution(s) to possibly license a couple of monoclonal antibodies to study. I wonder how that is going. Anyone remember if they said what the indications were?
(0)
(0)
